4746 — Formosa Laboratories Share Price
0.000.00%
Last trade - 00:00- TWD7.28bn
- TWD9.43bn
- TWD4.73bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.93 | ||
| Price to Tang. Book | 0.95 | ||
| Price to Free Cashflow | 51.42 | ||
| Price to Sales | 1.5 | ||
| EV to EBITDA | 7.53 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.29% | ||
| Return on Equity | 2.06% | ||
| Operating Margin | 15.34% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 3,075.46 | 3,142.41 | 3,765.5 | 4,360.45 | 4,731.05 | 5,025 | n/a | 11.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +2592.99 | +203.9 | -67.18 | -69.07 | +35.2 | +358.01 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Formosa Laboratories, Inc. is a Taiwan-based company principally engaged in the development, production and distribution of ultraviolet (UV)-proof active ingredients, bulk pharmaceutical chemicals, antibody drug conjugates, as well as the provision of customized services. The Company primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The Company distributes its products to Europe, the Americas, Asia and other markets.
Directors
- C.Y. Cheng CHM
- C.P. Yang CEO
- Michelle Lo DGM
- Hank Chen DGM
- Hengui Huang DGM
- Kevin Lee DGM
- Chien Hsing Lin DGM
- Josh Lin DGM
- Jessica Liou DGM
- Jeff Sung DGM
- J.C. Wung DGM
- Fannie Yang DGM
- Jianhong Li DRC
- Donghe Lin DRC
- Lujie Wang DRC
- Hongmin Xie DRC
- Zhihan Zhong DRC
- Dingkai Wu IND
- Zheren Zhuang IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 29th, 1995
- Public Since
- November 27th, 2009
- No. of Employees
- 480
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 120,256,000
- Address
- No.36, Hoping Street, Kengkou Village, TAOYUAN, 338
- Web
- https://www.formosalab.com/
- Phone
- +886 33240895
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 4746
Similar to 4746
Adimmune
Taiwan Stock Exchange
Bora Pharmaceuticals Co
Taiwan Stock Exchange
BRIM Biotechnology
Taiwan Stock Exchange
Caliway Biopharmaceuticals Co
Taiwan Stock Exchange
Cenra
Taiwan Stock Exchange
FAQ
What is the Formosa Laboratories share price?
As of Today at 20:40 UTC, shares in Formosa Laboratories are trading at TWD59.20. This share price information is delayed by 15 minutes.
How has the Formosa Laboratories share price performed this year?
Shares in Formosa Laboratories last closed at TWD59.20 and the price had moved by -40.8% over the past 365 days. In terms of relative price strength the Formosa Laboratories share price has underperformed the FTSE Developed Asia Pacific Index by -40.12% over the past year.
What are the analyst and broker recommendations for Formosa Laboratories?
The overall consensus recommendation for Formosa Laboratories is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Formosa Laboratories dividend yield?
The Formosa Laboratories dividend yield is 5.07% based on the trailing twelve month period.
Does Formosa Laboratories pay a dividend?
Last year, Formosa Laboratories paid a total dividend of TWD3.00, and it currently has a trailing dividend yield of 5.07%. We do not have any data on when Formosa Laboratories is to next pay dividends.
When does Formosa Laboratories next pay dividends?
We do not have data on when Formosa Laboratories is to next pay dividends. The historic dividend yield on Formosa Laboratories shares is currently 5.07%.
How do I buy Formosa Laboratories shares?
To buy shares in Formosa Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Formosa Laboratories?
As of the previous close price of TWD59.20, shares in Formosa Laboratories had a market capitalisation of TWD7.28bn.
Where are Formosa Laboratories shares listed?
Here are the trading details for Formosa Laboratories:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 4746
What kind of share is Formosa Laboratories?
Based on an overall assessment of its quality, value and momentum Formosa Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Formosa Laboratories share price forecast for 2025?
The analyst consensus target price for shares in Formosa Laboratories is TWD111.55. That is 88.43% above the last closing price of TWD59.20.
Analysts covering Formosa Laboratories currently have a consensus Earnings Per Share (EPS) forecast of TWD6.49 for the next financial year.
Find out moreWhat is the trend in the Formosa Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Formosa Laboratories. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -32.18%.
As of the last closing price of TWD59.20, shares in Formosa Laboratories were trading -28.65% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Formosa Laboratories PE Ratio?
The Formosa Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD59.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Formosa Laboratories?
Formosa Laboratories' management team is headed by:
- C.Y. Cheng - CHM
- C.P. Yang - CEO
- Michelle Lo - DGM
- Hank Chen - DGM
- Hengui Huang - DGM
- Kevin Lee - DGM
- Chien Hsing Lin - DGM
- Josh Lin - DGM
- Jessica Liou - DGM
- Jeff Sung - DGM
- J.C. Wung - DGM
- Fannie Yang - DGM
- Jianhong Li - DRC
- Donghe Lin - DRC
- Lujie Wang - DRC
- Hongmin Xie - DRC
- Zhihan Zhong - DRC
- Dingkai Wu - IND
- Zheren Zhuang - IND